LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

Search

Cytek Biosciences Inc

Cerrado

SectorSalud

3.22 -4.17

Resumen

Variación precio

24h

Actual

Mínimo

3.22

Máximo

3.31

Métricas clave

By Trading Economics

Ingresos

-21M

-11M

Ventas

-16M

41M

BPA

-0.027

Margen de beneficio

-27.503

Empleados

663

EBITDA

-13M

-15M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+71.13% upside

Dividendos

By Dow Jones

Próximas Ganancias

5 ago 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-42M

451M

Apertura anterior

7.39

Cierre anterior

3.22

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

155 / 381 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Weak Bullish Evidence

Cytek Biosciences Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

13 jun 2025, 22:33 UTC

Adquisiciones, fusiones, absorciones

Millicom to Acquire Telefonica Ecuador for $380 Million

14 jun 2025, 01:24 UTC

Adquisiciones, fusiones, absorciones

Nippon to Close U.S. Steel Deal After National-Security Pact With Trump -- 3rd Update

13 jun 2025, 23:50 UTC

Adquisiciones, fusiones, absorciones

Trump and Nippon Steel Reach National-Security Agreement on U.S. Steel Deal -- 2nd Update

13 jun 2025, 23:20 UTC

Adquisiciones, fusiones, absorciones

Trump and Nippon Steel Reach National-Security Agreement on U.S. Steel Deal -- Update

13 jun 2025, 23:09 UTC

Adquisiciones, fusiones, absorciones

Trump, Nippon Steel Reach National-Security Agreement on U.S. Steel Deal -- WSJ

13 jun 2025, 23:03 UTC

Adquisiciones, fusiones, absorciones

Trump, Nippon Steel Reach National-Security Agreement on U.S. Steel Deal --WSJ

13 jun 2025, 22:18 UTC

Adquisiciones, fusiones, absorciones

Millicom to Acquire Telefonica Ecuador for $380M

13 jun 2025, 22:04 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Better Data Facilitate Investments In Oil Patch -- Market Talk

13 jun 2025, 21:42 UTC

Adquisiciones, fusiones, absorciones

Anne Wojcicki Wins Bidding for 23andMe -- 2nd Update

13 jun 2025, 21:35 UTC

Adquisiciones, fusiones, absorciones

Bunge: Outside Date Extended to July 3

13 jun 2025, 21:35 UTC

Adquisiciones, fusiones, absorciones

Bunge: Subject to Satisfaction of Remaining Conditions, Bunge and Sellers Expect to Complete Transaction July 2

13 jun 2025, 21:34 UTC

Adquisiciones, fusiones, absorciones

Bunge Gets Mexico Approval for Viterra Deal

13 jun 2025, 21:32 UTC

Adquisiciones, fusiones, absorciones

Bunge Gets China Approval for Viterra Deal

13 jun 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

13 jun 2025, 20:45 UTC

Adquisiciones, fusiones, absorciones

23andMe: TTAM Makes Binding Commitments for Additional Consumer Protections and Privacy Safeguards

13 jun 2025, 20:34 UTC

Adquisiciones, fusiones, absorciones

Anne Wojcicki Wins Bidding for 23andMe -- Update

13 jun 2025, 20:14 UTC

Adquisiciones, fusiones, absorciones

Nonprofit Controlled By 23andMe Co-Founder Anne Wojcicki Would Buy the DNA-Testing Company for $305 Million -- WSJ

13 jun 2025, 20:14 UTC

Adquisiciones, fusiones, absorciones

Anne Wojcicki Wins Bidding for 23andMe -- WSJ

13 jun 2025, 20:14 UTC

Adquisiciones, fusiones, absorciones

Regeneron Walks Away From 23andMe Acquisition After Wojcicki's Higher Bid -- WSJ

13 jun 2025, 19:30 UTC

Charlas de Mercado

U.S. Natural Gas Futures Post Moderate Gains -- Market Talk

13 jun 2025, 19:12 UTC

Charlas de Mercado

Oil Futures Jump As Israel Strikes Iranian Targets -- Market Talk

13 jun 2025, 19:04 UTC

Charlas de Mercado

Canada Military Spending Hike to Lift Long-Term Yields -- Market Talk

13 jun 2025, 18:54 UTC

Charlas de Mercado

Correction to Gold Settles Market Talk

13 jun 2025, 18:01 UTC

Charlas de Mercado

Gold Settles at Record High -- Market Talk

13 jun 2025, 17:40 UTC

Charlas de Mercado

U.S. Oil Rig Count Falls By 3 to 439 -- Market Talk

13 jun 2025, 17:21 UTC

Charlas de Mercado

Dollar Index, Commodities Rise -- Market Talk

13 jun 2025, 17:02 UTC

Adquisiciones, fusiones, absorciones

Advent Proposal Values Spectris at GBP37.63 Per Share, Company Said Monday -- WSJ

13 jun 2025, 17:02 UTC

Adquisiciones, fusiones, absorciones

KKR Is Preparing a Bid for High-Tech Instrument Maker Spectris, Sources Say -- WSJ

13 jun 2025, 17:02 UTC

Adquisiciones, fusiones, absorciones

Private-Equity Firm Is Vying With Advent for the U.K. Company, Sources Say -- WSJ

13 jun 2025, 17:02 UTC

Adquisiciones, fusiones, absorciones

KKR Making Competing Bid for Equipment Maker Spectris -- WSJ

Comparación entre iguales

Cambio de precio

Cytek Biosciences Inc Esperado

Precio Objetivo

By TipRanks

71.13% repunte

Estimación a 12 meses

Media 5.75 USD  71.13%

Máximo 8 USD

Mínimo 4 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Cytek Biosciences Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

4 ratings

2

Comprar

2

Mantener

0

Vender

Puntuación técnica

By Trading Central

3.7 / 3.8Soporte y Resistencia

Corto Plazo

Weak Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

155 / 381 Clasificación en Salud

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Cytek Biosciences Inc

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.